Healthcare IT News November 27, 2024
Jessica Hagen

The announcement comes about four months after Musk relayed his vision for patients with an Optimus robotic arm or leg to have the ability to control their limbs with the N1 implant.

Elon Musk’s brain-computer interface implant startup Neuralink announced on X that it received approval to launch a new feasibility study, CONVOY, which will test the use of its wireless brain-computer interface (BCI), or N1 implant, to control an investigational assistive robotic arm.

“This is an important first step towards restoring not only digital freedom, but also physical freedom. More info to come, but the CONVOY Study will enable cross-enrolling participants from the ongoing PRIME Study,” Neuralink said in a post.

Neuralink’s PRIME study (short for Precise Robotically...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry
Cala Health Snags $50M for At-Home Tremor Relief Therapy

Share This Article